B6.129-Afg3l2tm1.1Alfb/Cnrm

Status

Available to order

EMMA IDEM:12806
International strain nameB6.129-Afg3l2tm1.1Alfb/Cnrm
Alternative nameAfg3l2(M665R)
Strain typeTargeted Mutant Strains : Point mutation
Allele/Transgene symbolAfg3l2tm1.1Alfb,
Gene/Transgene symbolAfg3l2

Information from provider

ProviderAlfredo Brusco
Provider affiliationDept. of Medical Sciences, University of Torino
Genetic informationKnock-in mice, in which the pathogenic mutation p(M665R), associated with spinocerebellar ataxia type 28, has been introduced in the murine Afg3l2 gene. Heterozygotes develop ataxia at late age (>18 months). Homozygotes die perinatally.
Phenotypic informationHomozygous:
Homozygotes die before or within hours of birth. Analysis of E16.5 embryos showed diffuse cardiac atrophy.

Heterozygous:
Heterozygotes developed ataxia at 18 months of age.
Breeding historyFounders have been backcrossed with C57BL/6 wild-type mice for more than 17 generations.
References
  • Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.;Mancini Cecilia, Hoxha Eriola, Iommarini Luisa, Brussino Alessandro, Richter Uwe, Montarolo Francesca, Cagnoli Claudia, Parolisi Roberta, Gondor Morosini Diana Iulia, Nicolò Valentina, Maltecca Francesca, Muratori Luisa, Ronchi Giulia, Geuna Stefano, Arnaboldi Francesca, Donetti Elena, Giorgio Elisa, Cavalieri Simona, Di Gregorio Eleonora, Pozzi Elisa, Ferrero Marta, Riberi Evelise, Casari Giorgio, Altruda Fiorella, Turco Emilia, Gasparre Giuseppe, Battersby Brendan J, Porcelli Anna Maria, Ferrero Enza, Brusco Alfredo, Tempia Filippo, ;2019;Neurobiology of disease;124;14-28; 30389403
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.;Mancini Cecilia, Hoxha Eriola, Iommarini Luisa, Brussino Alessandro, Richter Uwe, Montarolo Francesca, Cagnoli Claudia, Parolisi Roberta, Gondor Morosini Diana Iulia, Nicolò Valentina, Maltecca Francesca, Muratori Luisa, Ronchi Giulia, Geuna Stefano, Arnaboldi Francesca, Donetti Elena, Giorgio Elisa, Cavalieri Simona, Di Gregorio Eleonora, Pozzi Elisa, Ferrero Marta, Riberi Evelise, Casari Giorgio, Altruda Fiorella, Turco Emilia, Gasparre Giuseppe, Battersby Brendan J, Porcelli Anna Maria, Ferrero Enza, Brusco Alfredo, Tempia Filippo, ;2019;Neurobiology of disease;124;14-28; 30389403

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).